Trial Profile

A clinical trial of LV-009 for treatment of B-cell malignant tumors

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 24 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs LV 009 (Primary)
Indications B-cell leukaemia; B-cell lymphoma
Focus Therapeutic Use

Most Recent Events

24 Nov 2025 New trial record
29 Oct 2025 Accoridng to a Boshenji Pharmaceutical media release, LV009 injection has completed the first patient administration.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com